The global Candida Infections Drugs market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Azole Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Candida Infections Drugs include F. Hoffmann-La Roche Ltd, Mylan NV, Teva Pharmaceutical Industries Ltd, Sanofi, Pfizer Inc, GSK plc, Novartis AG, AstraZeneca and Johnson & Johnson Private Limited, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Candida infection is a yeast infection where the skin acts as a host organism, and the infection multiplies and grows with the period. Candida albicans are the most common species of this infection. Candida normally lives on the skin and inside the body, such as the throat, gut, mouth, and vagina, without causing problems. It can cause infections if it grows out of control or enters deep into the body.
This report aims to provide a comprehensive presentation of the global market for Candida Infections Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Candida Infections Drugs. This report contains market size and forecasts of Candida Infections Drugs in global, including the following market information:
Global Candida Infections Drugs Market Revenue, 2020-2024, 2025-2030, ($ millions)
Global Candida Infections Drugs Market Sales, 2020-2024, 2025-2030, (K Units)
Global top five Candida Infections Drugs companies in 2023 (%)
We surveyed the Candida Infections Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Candida Infections Drugs Market, by Type, 2020-2024, 2025-2030 ($ Millions) & (K Units)
Global Candida Infections Drugs Market Segment Percentages, by Type, 2023 (%)
Azole
Nystatin
Other
Global Candida Infections Drugs Market, by Application, 2020-2024, 2025-2030 ($ Millions) & (K Units)
Global Candida Infections Drugs Market Segment Percentages, by Application, 2023 (%)
Beriberi
Jock Itch
Vaginal Infection
Other
Global Candida Infections Drugs Market, By Region and Country, 2020-2024, 2025-2030 ($ Millions) & (K Units)
Global Candida Infections Drugs Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Candida Infections Drugs revenues in global market, 2020-2024 (Estimated), ($ millions)
Key companies Candida Infections Drugs revenues share in global market, 2023 (%)
Key companies Candida Infections Drugs sales in global market, 2020-2024 (Estimated), (K Units)
Key companies Candida Infections Drugs sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
F. Hoffmann-La Roche Ltd
Mylan NV
Teva Pharmaceutical Industries Ltd
Sanofi
Pfizer Inc
GSK plc
Novartis AG
AstraZeneca
Johnson & Johnson Private Limited
Sun Pharmaceutical Industries Ltd
Merck & Co., Inc
Bristol-Myers Squibb Company
Lilly
Amgen Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Candida Infections Drugs, market overview.
Chapter 2: Global Candida Infections Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Candida Infections Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Candida Infections Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Candida Infections Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Candida Infections Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Candida Infections Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Candida Infections Drugs Overall Market Size
2.1 Global Candida Infections Drugs Market Size: 2023 VS 2030
2.2 Global Candida Infections Drugs Revenue, Prospects & Forecasts: 2020-2030
2.3 Global Candida Infections Drugs Sales: 2020-2030
3 Company Landscape
3.1 Top Candida Infections Drugs Players in Global Market
3.2 Top Global Candida Infections Drugs Companies Ranked by Revenue
3.3 Global Candida Infections Drugs Revenue by Companies
3.4 Global Candida Infections Drugs Sales by Companies
3.5 Global Candida Infections Drugs Price by Manufacturer (2020-2024)
3.6 Top 3 and Top 5 Candida Infections Drugs Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Candida Infections Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Candida Infections Drugs Players in Global Market
3.8.1 List of Global Tier 1 Candida Infections Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Candida Infections Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Candida Infections Drugs Market Size Markets, 2023 & 2030
4.1.2 Azole
4.1.3 Nystatin
4.1.4 Other
4.2 By Type - Global Candida Infections Drugs Revenue & Forecasts
4.2.1 By Type - Global Candida Infections Drugs Revenue, 2020-2024
4.2.2 By Type - Global Candida Infections Drugs Revenue, 2025-2030
4.2.3 By Type - Global Candida Infections Drugs Revenue Market Share, 2020-2030
4.3 By Type - Global Candida Infections Drugs Sales & Forecasts
4.3.1 By Type - Global Candida Infections Drugs Sales, 2020-2024
4.3.2 By Type - Global Candida Infections Drugs Sales, 2025-2030
4.3.3 By Type - Global Candida Infections Drugs Sales Market Share, 2020-2030
4.4 By Type - Global Candida Infections Drugs Price (Manufacturers Selling Prices), 2020-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Candida Infections Drugs Market Size, 2023 & 2030
5.1.2 Beriberi
5.1.3 Jock Itch
5.1.4 Vaginal Infection
5.1.5 Other
5.2 By Application - Global Candida Infections Drugs Revenue & Forecasts
5.2.1 By Application - Global Candida Infections Drugs Revenue, 2020-2024
5.2.2 By Application - Global Candida Infections Drugs Revenue, 2025-2030
5.2.3 By Application - Global Candida Infections Drugs Revenue Market Share, 2020-2030
5.3 By Application - Global Candida Infections Drugs Sales & Forecasts
5.3.1 By Application - Global Candida Infections Drugs Sales, 2020-2024
5.3.2 By Application - Global Candida Infections Drugs Sales, 2025-2030
5.3.3 By Application - Global Candida Infections Drugs Sales Market Share, 2020-2030
5.4 By Application - Global Candida Infections Drugs Price (Manufacturers Selling Prices), 2020-2030
6 Sights by Region
6.1 By Region - Global Candida Infections Drugs Market Size, 2023 & 2030
6.2 By Region - Global Candida Infections Drugs Revenue & Forecasts
6.2.1 By Region - Global Candida Infections Drugs Revenue, 2020-2024
6.2.2 By Region - Global Candida Infections Drugs Revenue, 2025-2030
6.2.3 By Region - Global Candida Infections Drugs Revenue Market Share, 2020-2030
6.3 By Region - Global Candida Infections Drugs Sales & Forecasts
6.3.1 By Region - Global Candida Infections Drugs Sales, 2020-2024
6.3.2 By Region - Global Candida Infections Drugs Sales, 2025-2030
6.3.3 By Region - Global Candida Infections Drugs Sales Market Share, 2020-2030
6.4 North America
6.4.1 By Country - North America Candida Infections Drugs Revenue, 2020-2030
6.4.2 By Country - North America Candida Infections Drugs Sales, 2020-2030
6.4.3 US Candida Infections Drugs Market Size, 2020-2030
6.4.4 Canada Candida Infections Drugs Market Size, 2020-2030
6.4.5 Mexico Candida Infections Drugs Market Size, 2020-2030
6.5 Europe
6.5.1 By Country - Europe Candida Infections Drugs Revenue, 2020-2030
6.5.2 By Country - Europe Candida Infections Drugs Sales, 2020-2030
6.5.3 Germany Candida Infections Drugs Market Size, 2020-2030
6.5.4 France Candida Infections Drugs Market Size, 2020-2030
6.5.5 U.K. Candida Infections Drugs Market Size, 2020-2030
6.5.6 Italy Candida Infections Drugs Market Size, 2020-2030
6.5.7 Russia Candida Infections Drugs Market Size, 2020-2030
6.5.8 Nordic Countries Candida Infections Drugs Market Size, 2020-2030
6.5.9 Benelux Candida Infections Drugs Market Size, 2020-2030
6.6 Asia
6.6.1 By Region - Asia Candida Infections Drugs Revenue, 2020-2030
6.6.2 By Region - Asia Candida Infections Drugs Sales, 2020-2030
6.6.3 China Candida Infections Drugs Market Size, 2020-2030
6.6.4 Japan Candida Infections Drugs Market Size, 2020-2030
6.6.5 South Korea Candida Infections Drugs Market Size, 2020-2030
6.6.6 Southeast Asia Candida Infections Drugs Market Size, 2020-2030
6.6.7 India Candida Infections Drugs Market Size, 2020-2030
6.7 South America
6.7.1 By Country - South America Candida Infections Drugs Revenue, 2020-2030
6.7.2 By Country - South America Candida Infections Drugs Sales, 2020-2030
6.7.3 Brazil Candida Infections Drugs Market Size, 2020-2030
6.7.4 Argentina Candida Infections Drugs Market Size, 2020-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Candida Infections Drugs Revenue, 2020-2030
6.8.2 By Country - Middle East & Africa Candida Infections Drugs Sales, 2020-2030
6.8.3 Turkey Candida Infections Drugs Market Size, 2020-2030
6.8.4 Israel Candida Infections Drugs Market Size, 2020-2030
6.8.5 Saudi Arabia Candida Infections Drugs Market Size, 2020-2030
6.8.6 UAE Candida Infections Drugs Market Size, 2020-2030
7 Manufacturers & Brands Profiles
7.1 F. Hoffmann-La Roche Ltd
7.1.1 F. Hoffmann-La Roche Ltd Company Summary
7.1.2 F. Hoffmann-La Roche Ltd Business Overview
7.1.3 F. Hoffmann-La Roche Ltd Candida Infections Drugs Major Product Offerings
7.1.4 F. Hoffmann-La Roche Ltd Candida Infections Drugs Sales and Revenue in Global (2020-2024)
7.1.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.2 Mylan NV
7.2.1 Mylan NV Company Summary
7.2.2 Mylan NV Business Overview
7.2.3 Mylan NV Candida Infections Drugs Major Product Offerings
7.2.4 Mylan NV Candida Infections Drugs Sales and Revenue in Global (2020-2024)
7.2.5 Mylan NV Key News & Latest Developments
7.3 Teva Pharmaceutical Industries Ltd
7.3.1 Teva Pharmaceutical Industries Ltd Company Summary
7.3.2 Teva Pharmaceutical Industries Ltd Business Overview
7.3.3 Teva Pharmaceutical Industries Ltd Candida Infections Drugs Major Product Offerings
7.3.4 Teva Pharmaceutical Industries Ltd Candida Infections Drugs Sales and Revenue in Global (2020-2024)
7.3.5 Teva Pharmaceutical Industries Ltd Key News & Latest Developments
7.4 Sanofi
7.4.1 Sanofi Company Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Candida Infections Drugs Major Product Offerings
7.4.4 Sanofi Candida Infections Drugs Sales and Revenue in Global (2020-2024)
7.4.5 Sanofi Key News & Latest Developments
7.5 Pfizer Inc
7.5.1 Pfizer Inc Company Summary
7.5.2 Pfizer Inc Business Overview
7.5.3 Pfizer Inc Candida Infections Drugs Major Product Offerings
7.5.4 Pfizer Inc Candida Infections Drugs Sales and Revenue in Global (2020-2024)
7.5.5 Pfizer Inc Key News & Latest Developments
7.6 GSK plc
7.6.1 GSK plc Company Summary
7.6.2 GSK plc Business Overview
7.6.3 GSK plc Candida Infections Drugs Major Product Offerings
7.6.4 GSK plc Candida Infections Drugs Sales and Revenue in Global (2020-2024)
7.6.5 GSK plc Key News & Latest Developments
7.7 Novartis AG
7.7.1 Novartis AG Company Summary
7.7.2 Novartis AG Business Overview
7.7.3 Novartis AG Candida Infections Drugs Major Product Offerings
7.7.4 Novartis AG Candida Infections Drugs Sales and Revenue in Global (2020-2024)
7.7.5 Novartis AG Key News & Latest Developments
7.8 AstraZeneca
7.8.1 AstraZeneca Company Summary
7.8.2 AstraZeneca Business Overview
7.8.3 AstraZeneca Candida Infections Drugs Major Product Offerings
7.8.4 AstraZeneca Candida Infections Drugs Sales and Revenue in Global (2020-2024)
7.8.5 AstraZeneca Key News & Latest Developments
7.9 Johnson & Johnson Private Limited
7.9.1 Johnson & Johnson Private Limited Company Summary
7.9.2 Johnson & Johnson Private Limited Business Overview
7.9.3 Johnson & Johnson Private Limited Candida Infections Drugs Major Product Offerings
7.9.4 Johnson & Johnson Private Limited Candida Infections Drugs Sales and Revenue in Global (2020-2024)
7.9.5 Johnson & Johnson Private Limited Key News & Latest Developments
7.10 Sun Pharmaceutical Industries Ltd
7.10.1 Sun Pharmaceutical Industries Ltd Company Summary
7.10.2 Sun Pharmaceutical Industries Ltd Business Overview
7.10.3 Sun Pharmaceutical Industries Ltd Candida Infections Drugs Major Product Offerings
7.10.4 Sun Pharmaceutical Industries Ltd Candida Infections Drugs Sales and Revenue in Global (2020-2024)
7.10.5 Sun Pharmaceutical Industries Ltd Key News & Latest Developments
7.11 Merck & Co., Inc
7.11.1 Merck & Co., Inc Company Summary
7.11.2 Merck & Co., Inc Candida Infections Drugs Business Overview
7.11.3 Merck & Co., Inc Candida Infections Drugs Major Product Offerings
7.11.4 Merck & Co., Inc Candida Infections Drugs Sales and Revenue in Global (2020-2024)
7.11.5 Merck & Co., Inc Key News & Latest Developments
7.12 Bristol-Myers Squibb Company
7.12.1 Bristol-Myers Squibb Company Company Summary
7.12.2 Bristol-Myers Squibb Company Candida Infections Drugs Business Overview
7.12.3 Bristol-Myers Squibb Company Candida Infections Drugs Major Product Offerings
7.12.4 Bristol-Myers Squibb Company Candida Infections Drugs Sales and Revenue in Global (2020-2024)
7.12.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.13 Lilly
7.13.1 Lilly Company Summary
7.13.2 Lilly Candida Infections Drugs Business Overview
7.13.3 Lilly Candida Infections Drugs Major Product Offerings
7.13.4 Lilly Candida Infections Drugs Sales and Revenue in Global (2020-2024)
7.13.5 Lilly Key News & Latest Developments
7.14 Amgen Inc
7.14.1 Amgen Inc Company Summary
7.14.2 Amgen Inc Business Overview
7.14.3 Amgen Inc Candida Infections Drugs Major Product Offerings
7.14.4 Amgen Inc Candida Infections Drugs Sales and Revenue in Global (2020-2024)
7.14.5 Amgen Inc Key News & Latest Developments
8 Global Candida Infections Drugs Production Capacity, Analysis
8.1 Global Candida Infections Drugs Production Capacity, 2020-2030
8.2 Candida Infections Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Candida Infections Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Candida Infections Drugs Supply Chain Analysis
10.1 Candida Infections Drugs Industry Value Chain
10.2 Candida Infections Drugs Upstream Market
10.3 Candida Infections Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Candida Infections Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Candida Infections Drugs in Global Market
Table 2. Top Candida Infections Drugs Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Candida Infections Drugs Revenue by Companies, (US$, Mn), 2020-2024
Table 4. Global Candida Infections Drugs Revenue Share by Companies, 2020-2024
Table 5. Global Candida Infections Drugs Sales by Companies, (K Units), 2020-2024
Table 6. Global Candida Infections Drugs Sales Share by Companies, 2020-2024
Table 7. Key Manufacturers Candida Infections Drugs Price (2020-2024) & (US$/Unit)
Table 8. Global Manufacturers Candida Infections Drugs Product Type
Table 9. List of Global Tier 1 Candida Infections Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Candida Infections Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Candida Infections Drugs Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Candida Infections Drugs Revenue (US$, Mn), 2020-2024
Table 13. By Type - Global Candida Infections Drugs Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Candida Infections Drugs Sales (K Units), 2020-2024
Table 15. By Type - Global Candida Infections Drugs Sales (K Units), 2025-2030
Table 16. By Application ? Global Candida Infections Drugs Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Candida Infections Drugs Revenue (US$, Mn), 2020-2024
Table 18. By Application - Global Candida Infections Drugs Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Candida Infections Drugs Sales (K Units), 2020-2024
Table 20. By Application - Global Candida Infections Drugs Sales (K Units), 2025-2030
Table 21. By Region ? Global Candida Infections Drugs Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Candida Infections Drugs Revenue (US$, Mn), 2020-2024
Table 23. By Region - Global Candida Infections Drugs Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Candida Infections Drugs Sales (K Units), 2020-2024
Table 25. By Region - Global Candida Infections Drugs Sales (K Units), 2025-2030
Table 26. By Country - North America Candida Infections Drugs Revenue, (US$, Mn), 2020-2024
Table 27. By Country - North America Candida Infections Drugs Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Candida Infections Drugs Sales, (K Units), 2020-2024
Table 29. By Country - North America Candida Infections Drugs Sales, (K Units), 2025-2030
Table 30. By Country - Europe Candida Infections Drugs Revenue, (US$, Mn), 2020-2024
Table 31. By Country - Europe Candida Infections Drugs Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Candida Infections Drugs Sales, (K Units), 2020-2024
Table 33. By Country - Europe Candida Infections Drugs Sales, (K Units), 2025-2030
Table 34. By Region - Asia Candida Infections Drugs Revenue, (US$, Mn), 2020-2024
Table 35. By Region - Asia Candida Infections Drugs Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Candida Infections Drugs Sales, (K Units), 2020-2024
Table 37. By Region - Asia Candida Infections Drugs Sales, (K Units), 2025-2030
Table 38. By Country - South America Candida Infections Drugs Revenue, (US$, Mn), 2020-2024
Table 39. By Country - South America Candida Infections Drugs Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Candida Infections Drugs Sales, (K Units), 2020-2024
Table 41. By Country - South America Candida Infections Drugs Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Candida Infections Drugs Revenue, (US$, Mn), 2020-2024
Table 43. By Country - Middle East & Africa Candida Infections Drugs Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Candida Infections Drugs Sales, (K Units), 2020-2024
Table 45. By Country - Middle East & Africa Candida Infections Drugs Sales, (K Units), 2025-2030
Table 46. F. Hoffmann-La Roche Ltd Company Summary
Table 47. F. Hoffmann-La Roche Ltd Candida Infections Drugs Product Offerings
Table 48. F. Hoffmann-La Roche Ltd Candida Infections Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2020-2024)
Table 49. F. Hoffmann-La Roche Ltd Key News & Latest Developments
Table 50. Mylan NV Company Summary
Table 51. Mylan NV Candida Infections Drugs Product Offerings
Table 52. Mylan NV Candida Infections Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2020-2024)
Table 53. Mylan NV Key News & Latest Developments
Table 54. Teva Pharmaceutical Industries Ltd Company Summary
Table 55. Teva Pharmaceutical Industries Ltd Candida Infections Drugs Product Offerings
Table 56. Teva Pharmaceutical Industries Ltd Candida Infections Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2020-2024)
Table 57. Teva Pharmaceutical Industries Ltd Key News & Latest Developments
Table 58. Sanofi Company Summary
Table 59. Sanofi Candida Infections Drugs Product Offerings
Table 60. Sanofi Candida Infections Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2020-2024)
Table 61. Sanofi Key News & Latest Developments
Table 62. Pfizer Inc Company Summary
Table 63. Pfizer Inc Candida Infections Drugs Product Offerings
Table 64. Pfizer Inc Candida Infections Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2020-2024)
Table 65. Pfizer Inc Key News & Latest Developments
Table 66. GSK plc Company Summary
Table 67. GSK plc Candida Infections Drugs Product Offerings
Table 68. GSK plc Candida Infections Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2020-2024)
Table 69. GSK plc Key News & Latest Developments
Table 70. Novartis AG Company Summary
Table 71. Novartis AG Candida Infections Drugs Product Offerings
Table 72. Novartis AG Candida Infections Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2020-2024)
Table 73. Novartis AG Key News & Latest Developments
Table 74. AstraZeneca Company Summary
Table 75. AstraZeneca Candida Infections Drugs Product Offerings
Table 76. AstraZeneca Candida Infections Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2020-2024)
Table 77. AstraZeneca Key News & Latest Developments
Table 78. Johnson & Johnson Private Limited Company Summary
Table 79. Johnson & Johnson Private Limited Candida Infections Drugs Product Offerings
Table 80. Johnson & Johnson Private Limited Candida Infections Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2020-2024)
Table 81. Johnson & Johnson Private Limited Key News & Latest Developments
Table 82. Sun Pharmaceutical Industries Ltd Company Summary
Table 83. Sun Pharmaceutical Industries Ltd Candida Infections Drugs Product Offerings
Table 84. Sun Pharmaceutical Industries Ltd Candida Infections Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2020-2024)
Table 85. Sun Pharmaceutical Industries Ltd Key News & Latest Developments
Table 86. Merck & Co., Inc Company Summary
Table 87. Merck & Co., Inc Candida Infections Drugs Product Offerings
Table 88. Merck & Co., Inc Candida Infections Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2020-2024)
Table 89. Merck & Co., Inc Key News & Latest Developments
Table 90. Bristol-Myers Squibb Company Company Summary
Table 91. Bristol-Myers Squibb Company Candida Infections Drugs Product Offerings
Table 92. Bristol-Myers Squibb Company Candida Infections Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2020-2024)
Table 93. Bristol-Myers Squibb Company Key News & Latest Developments
Table 94. Lilly Company Summary
Table 95. Lilly Candida Infections Drugs Product Offerings
Table 96. Lilly Candida Infections Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2020-2024)
Table 97. Lilly Key News & Latest Developments
Table 98. Amgen Inc Company Summary
Table 99. Amgen Inc Candida Infections Drugs Product Offerings
Table 100. Amgen Inc Candida Infections Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2020-2024)
Table 101. Amgen Inc Key News & Latest Developments
Table 102. Candida Infections Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 103. Global Candida Infections Drugs Capacity Market Share of Key Manufacturers, 2021-2024
Table 104. Global Candida Infections Drugs Production by Region, 2020-2024 (K Units)
Table 105. Global Candida Infections Drugs Production by Region, 2025-2030 (K Units)
Table 106. Candida Infections Drugs Market Opportunities & Trends in Global Market
Table 107. Candida Infections Drugs Market Drivers in Global Market
Table 108. Candida Infections Drugs Market Restraints in Global Market
Table 109. Candida Infections Drugs Raw Materials
Table 110. Candida Infections Drugs Raw Materials Suppliers in Global Market
Table 111. Typical Candida Infections Drugs Downstream
Table 112. Candida Infections Drugs Downstream Clients in Global Market
Table 113. Candida Infections Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Candida Infections Drugs Segment by Type in 2023
Figure 2. Candida Infections Drugs Segment by Application in 2023
Figure 3. Global Candida Infections Drugs Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Candida Infections Drugs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Candida Infections Drugs Revenue, 2020-2030 (US$, Mn)
Figure 7. Candida Infections Drugs Sales in Global Market: 2020-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Candida Infections Drugs Revenue in 2023
Figure 9. By Type - Global Candida Infections Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Candida Infections Drugs Revenue Market Share, 2020-2030
Figure 11. By Type - Global Candida Infections Drugs Sales Market Share, 2020-2030
Figure 12. By Type - Global Candida Infections Drugs Price (US$/Unit), 2020-2030
Figure 13. By Application - Global Candida Infections Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Candida Infections Drugs Revenue Market Share, 2020-2030
Figure 15. By Application - Global Candida Infections Drugs Sales Market Share, 2020-2030
Figure 16. By Application - Global Candida Infections Drugs Price (US$/Unit), 2020-2030
Figure 17. By Region - Global Candida Infections Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Candida Infections Drugs Revenue Market Share, 2020 VS 2023 VS 2030
Figure 19. By Region - Global Candida Infections Drugs Revenue Market Share, 2020-2030
Figure 20. By Region - Global Candida Infections Drugs Sales Market Share, 2020-2030
Figure 21. By Country - North America Candida Infections Drugs Revenue Market Share, 2020-2030
Figure 22. By Country - North America Candida Infections Drugs Sales Market Share, 2020-2030
Figure 23. US Candida Infections Drugs Revenue, (US$, Mn), 2020-2030
Figure 24. Canada Candida Infections Drugs Revenue, (US$, Mn), 2020-2030
Figure 25. Mexico Candida Infections Drugs Revenue, (US$, Mn), 2020-2030
Figure 26. By Country - Europe Candida Infections Drugs Revenue Market Share, 2020-2030
Figure 27. By Country - Europe Candida Infections Drugs Sales Market Share, 2020-2030
Figure 28. Germany Candida Infections Drugs Revenue, (US$, Mn), 2020-2030
Figure 29. France Candida Infections Drugs Revenue, (US$, Mn), 2020-2030
Figure 30. U.K. Candida Infections Drugs Revenue, (US$, Mn), 2020-2030
Figure 31. Italy Candida Infections Drugs Revenue, (US$, Mn), 2020-2030
Figure 32. Russia Candida Infections Drugs Revenue, (US$, Mn), 2020-2030
Figure 33. Nordic Countries Candida Infections Drugs Revenue, (US$, Mn), 2020-2030
Figure 34. Benelux Candida Infections Drugs Revenue, (US$, Mn), 2020-2030
Figure 35. By Region - Asia Candida Infections Drugs Revenue Market Share, 2020-2030
Figure 36. By Region - Asia Candida Infections Drugs Sales Market Share, 2020-2030
Figure 37. China Candida Infections Drugs Revenue, (US$, Mn), 2020-2030
Figure 38. Japan Candida Infections Drugs Revenue, (US$, Mn), 2020-2030
Figure 39. South Korea Candida Infections Drugs Revenue, (US$, Mn), 2020-2030
Figure 40. Southeast Asia Candida Infections Drugs Revenue, (US$, Mn), 2020-2030
Figure 41. India Candida Infections Drugs Revenue, (US$, Mn), 2020-2030
Figure 42. By Country - South America Candida Infections Drugs Revenue Market Share, 2020-2030
Figure 43. By Country - South America Candida Infections Drugs Sales Market Share, 2020-2030
Figure 44. Brazil Candida Infections Drugs Revenue, (US$, Mn), 2020-2030
Figure 45. Argentina Candida Infections Drugs Revenue, (US$, Mn), 2020-2030
Figure 46. By Country - Middle East & Africa Candida Infections Drugs Revenue Market Share, 2020-2030
Figure 47. By Country - Middle East & Africa Candida Infections Drugs Sales Market Share, 2020-2030
Figure 48. Turkey Candida Infections Drugs Revenue, (US$, Mn), 2020-2030
Figure 49. Israel Candida Infections Drugs Revenue, (US$, Mn), 2020-2030
Figure 50. Saudi Arabia Candida Infections Drugs Revenue, (US$, Mn), 2020-2030
Figure 51. UAE Candida Infections Drugs Revenue, (US$, Mn), 2020-2030
Figure 52. Global Candida Infections Drugs Production Capacity (K Units), 2020-2030
Figure 53. The Percentage of Production Candida Infections Drugs by Region, 2023 VS 2030
Figure 54. Candida Infections Drugs Industry Value Chain
Figure 55. Marketing Channels
